Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan M Granoff

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
Infection and Immunity|November 26, 2003
Conformational epitopes recognized by protective anti-neisserial surface protein A antibodiesVictor C Hou, Gregory R Moe, Zyde Raad, et al.
Haematologica|February 2, 2019
Differential effects of therapeutic complement inhibitors on serum bactericidal activity against non-groupable meningococcal isolates recovered from patients treated with eculizumabDan M Granoff, Howard Kim, Nadav Topaz, et al.
Mbio|June 20, 2019
A Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Mutant FHbp Elicits Higher Protective Antibody Responses in Infant Rhesus Macaques than a Licensed Serogroup B VaccinePeter T Beernink, Vianca Vianzon, Lisa A Lewis, et al.
Mbio|October 17, 2013
Factor H-dependent alternative pathway inhibition mediated by porin B contributes to virulence of Neisseria meningitidisLisa A Lewis, David M Vu, Shreekant Vasudhev, et al.
Vaccine|February 10, 2015
A native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic miceRolando Pajon, Carolyn M Buckwalter, Kay O Johswich, et al.
Vaccine|May 17, 2011
Immunogenicity of a meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and over-expressed factor H binding protein in infant rhesus monkeysOliver Koeberling, Anja Seubert, George Santos, et al.
Plos Pathogens|May 17, 2012
The effect of human factor H on immunogenicity of meningococcal native outer membrane vesicle vaccines with over-expressed factor H binding proteinPeter T Beernink, Jutamas Shaughnessy, Rolando Pajon, et al.
Infection and Immunity|September 22, 2020
Neisseria meningitidis Urethritis Outbreak Isolates Express a Novel Factor H Binding Protein Variant That Is a Potential Target of Group B-Directed Meningococcal (MenB) VaccinesYih-Ling Tzeng, Serena Giuntini, Zachary Berman, et al.
JCI Insight|September 27, 2016
Enhanced protective antibody to a mutant meningococcal factor H-binding protein with low-factor H bindingDan M Granoff, Serena Giuntini, Flor A Gowans, et al.
The Journal of Infectious Diseases|November 26, 2003
Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activityJo Anne Welsch, Gregory R Moe, Raffaella Rossi, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Infection and Immunity|November 26, 2003
Conformational epitopes recognized by protective anti-neisserial surface protein A antibodiesVictor C Hou, Gregory R Moe, Zyde Raad, et al.
Haematologica|February 2, 2019
Differential effects of therapeutic complement inhibitors on serum bactericidal activity against non-groupable meningococcal isolates recovered from patients treated with eculizumabDan M Granoff, Howard Kim, Nadav Topaz, et al.
Mbio|June 20, 2019
A Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Mutant FHbp Elicits Higher Protective Antibody Responses in Infant Rhesus Macaques than a Licensed Serogroup B VaccinePeter T Beernink, Vianca Vianzon, Lisa A Lewis, et al.
Mbio|October 17, 2013
Factor H-dependent alternative pathway inhibition mediated by porin B contributes to virulence of Neisseria meningitidisLisa A Lewis, David M Vu, Shreekant Vasudhev, et al.
Vaccine|February 10, 2015
A native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic miceRolando Pajon, Carolyn M Buckwalter, Kay O Johswich, et al.
Vaccine|May 17, 2011
Immunogenicity of a meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and over-expressed factor H binding protein in infant rhesus monkeysOliver Koeberling, Anja Seubert, George Santos, et al.
Plos Pathogens|May 17, 2012
The effect of human factor H on immunogenicity of meningococcal native outer membrane vesicle vaccines with over-expressed factor H binding proteinPeter T Beernink, Jutamas Shaughnessy, Rolando Pajon, et al.
Infection and Immunity|September 22, 2020
Neisseria meningitidis Urethritis Outbreak Isolates Express a Novel Factor H Binding Protein Variant That Is a Potential Target of Group B-Directed Meningococcal (MenB) VaccinesYih-Ling Tzeng, Serena Giuntini, Zachary Berman, et al.
JCI Insight|September 27, 2016
Enhanced protective antibody to a mutant meningococcal factor H-binding protein with low-factor H bindingDan M Granoff, Serena Giuntini, Flor A Gowans, et al.
The Journal of Infectious Diseases|November 26, 2003
Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activityJo Anne Welsch, Gregory R Moe, Raffaella Rossi, et al.
Pageof 10